Breaking newsEAN NewsCOVID-19Research
Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis
Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
Breaking newsEAN NewsCOVID-19ResearchNeuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study -
Breaking newsEAN NewsCOVID-19ResearchThe mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts
The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts -
Breaking newsEAN NewsCOVID-19ResearchSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK -
Breaking newsEAN NewsCOVID-19ResearchComparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study -
Breaking newsEAN NewsCOVID-19Research
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis -
Breaking newsEAN NewsCOVID-19Research
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine -
Breaking newsEAN NewsCOVID-19Research
Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19
Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 -
Breaking newsEAN NewsCOVID-19Research
Efficacy of Tocilizumab in Patients Hospitalized with COVID-19
Efficacy of Tocilizumab in Patients Hospitalized with COVID-19 -
Breaking newsEAN NewsCOVID-19Research
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19 -
Breaking newsEAN NewsCOVID-19Research
A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19
A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19 -
Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
-
Executive PageEAN NewsFeatured SliderExecutive Page: Happy New Year 2021 from the EAN, the Home of Neurology
Happy New Year 2021 from the EAN, the Home of Neurology -
Paper of the MonthEAN NewsCOVID-19COVID-19 Paper of the month: Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2. -
News in generalOther NewsJoint strategy sets direction for EMA and EU medicines regulatory agencies to 2025
EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.